Millions of women are purchasing pain medication that may be less effective for treating period cramps [3].

This trend suggests a significant gap between consumer purchasing habits and medical efficacy regarding menstrual pain management. When women choose the wrong medication, they may experience prolonged discomfort or unnecessary dosing of less effective drugs.

Data from high-street retailers and supermarkets in the U.S. and UK highlight the discrepancy [2]. An analysis of 211 million receipts revealed that paracetamol, also known as acetaminophen, is the most common painkiller bought alongside menstrual products [1, 2].

Medical evidence indicates that ibuprofen typically provides better relief for menstrual cramps than paracetamol [4]. Despite this, acetaminophen remains more commonly used for this specific purpose [4].

Retail patterns show that women frequently pair menstrual products with paracetamol during shopping trips [2]. This suggests that the choice of medication is often made at the point of sale or based on general habit rather than targeted symptom relief.

While paracetamol is a widely available over-the-counter option, its mechanism of action differs from nonsteroidal anti-inflammatory drugs like ibuprofen. The latter specifically targets the prostaglandins that cause the uterine contractions associated with cramping [4].

“Millions of women are purchasing pain medication that may be less effective for treating period cramps.”

The reliance on paracetamol for menstrual pain reflects a broader issue of health literacy and the influence of retail availability over clinical guidance. Because ibuprofen targets the specific biological cause of menstrual cramps, prostaglandins, its prevalence in retail baskets is lower than its clinical utility would suggest. This gap indicates a need for clearer labeling or better pharmacy guidance at the point of purchase.